Skip to main content
MDT
NYSE Life Sciences

美敦力获得ViaVerte系统的独家分销权，进一步增强其疼痛管理产品组合

feedReported by dpa-AFX
Sentiment info
Positive
Importance info
7
Price
$87.17
Mkt Cap
$111.916B
52W Low
$79.55
52W High
$106.33
Market data snapshot near publication time

summarizeSummary

美敦力与Merit Medical Systems签订了独家分销协议，提供FDA批准的ViaVerte系统，该系统是一种用于慢性下背痛的微创性基椎神经消融（BVNA）系统。这种战略合作扩大了美敦力的综合疼痛干预产品组合，在其产品中添加了独特的、医生控制的可控导向机构。该协议加强了美敦力在其核心业务中的领导地位，此前其OmniaSecure除颤导管获得FDA批准的扩大适应症。对于像美敦力这样规模的公司来说，这是一个渐进的举动，但它代表着在扩大治疗选择和巩固其市场地位方面是一个积极的步骤。交易者应该关注ViaVerte系统的市场接受度和收入贡献。

在该公告发布时，MDT的交易价格为$87.17，交易所为NYSE，所属行业为Life Sciences，市值约为$1119.2亿。 52周交易区间为$79.55至$106.33。 这则新闻被评估为积极市场情绪，重要性评分为7/10。 来源：dpa-AFX。

show_chartPrice Chart

Share this article

Copied!

feed MDT - Latest Insights

MDT
Apr 25, 2026, 12:34 PM EDT
Source: Reuters
Importance Score:
8
Medtronic's Sphere-9 Catheter for VT Earns FDA Breakthrough Device Designation
Sentiment: Positive
View Wiseek Article
MDT
Apr 23, 2026, 8:14 AM EDT
Source: Reuters
Importance Score:
8
US to Speed Up Medicare Payments for New Medical Devices, Cutting Reimbursement Wait Times to Two Months
Sentiment: Positive
View Wiseek Article
MDT
Apr 20, 2026, 7:50 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Medtronic Finalizes CathWorks Acquisition, Bolstering Cardiovascular Leadership
Sentiment: Positive
View Wiseek Article
MDT
Mar 27, 2026, 9:01 AM EDT
Source: Reuters
Importance Score:
7
FDA Clears Medtronic's Stealth Axis™ Surgical System for Cranial, ENT Procedures
Sentiment: Positive
View Wiseek Article
MDT
Mar 24, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
8
Medtronic Cuts FY26 EPS Guidance by Over 2% on MiniMed Flex Charge, Dilution
Sentiment: Negative
View Wiseek Article
MDT
Mar 24, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
7
Medtronic Lowers FY2026 EPS Guidance by $0.12/Share Due to MiniMed Flex Launch Costs and IPO Dilution
Sentiment: Negative
View Wiseek Article
MDT
Mar 24, 2026, 9:25 AM EDT
Source: dpa-AFX
Importance Score:
7
Medtronic Secures Exclusive Distribution for FDA-Approved ViaVerte System, Bolstering Pain Portfolio
Sentiment: Positive
View Wiseek Article
MDT
Mar 23, 2026, 9:38 AM EDT
Source: dpa-AFX
Importance Score:
7
Medtronic's OmniaSecure Lead First to Win FDA Approval for Advanced Cardiac Pacing
Sentiment: Positive
View Wiseek Article
MDT
Mar 10, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Medtronic to Acquire Scientia Vascular, Expanding Medical Device Portfolio
Sentiment: Neutral
View Wiseek Article
MDT
Mar 06, 2026, 12:11 PM EST
Source: Reuters
Importance Score:
8
Medtronic's MiniMed Unit Shares Drop 4.8% in Nasdaq Debut, Valued at $5.3 Billion
Sentiment: Negative
View Wiseek Article